Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 1 (2004), Issue 4 (November)

1. Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
   Int J Cancer, 113(1): 88-92. [Abstract] [Full-text]
2. Features of sentinel lymph nodes for melanoma may lead to re-diagnosis of the cutaneous primary: an unusual case and review of literature.
   Virchows Arch, 445(5): 527-30. [Abstract] [Full-text]
3. Loss of heterozygosity at 12p13 and loss of p27KIP1 protein expression contribute to melanoma progression.
   Virchows Arch, 445(5): 491-7. [Abstract] [Full-text]
4. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes.
   Cancer Res, 64(21): 8068-76. [Abstract] [Full-text]
5. Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway.
   Cancer Res, 64(21): 7706-10. [Abstract] [Full-text]
6. CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.
   Cancer Res, 64(21): 7697-701. [Abstract] [Full-text]
7. Epidemiological differences for cutaneous melanoma in a relatively dark-skinned Caucasian population with chronic sun exposure.
   Eur J Cancer, 40(16): 2502-7. [Abstract] [Full-text]
8. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.
   Eur J Cancer, 40(16): 2389-95. [Abstract] [Full-text]
9. Perspectives in melanoma prevention: the case of sunbeds.
   Eur J Cancer, 40(16): 2367-76. [Abstract] [Full-text]
10. Cutaneous malignant melanoma in Europe.
    Eur J Cancer, 40(16): 2355-66. [Abstract] [Full-text]
11. Chemokine receptors and melanoma metastasis.
    J Dermatol Sci, 36(2): 71-8. [Abstract] [Full-text]
12. Prolonged evolution of a lentigo maligna.
    J Am Acad Dermatol, 51(5): 830-5. [Abstract] [Full-text]
13. Genetic testing in hereditary melanoma.
    J Am Acad Dermatol, 51(5): 803-8. [Abstract] [Full-text]
14. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    J Natl Cancer Inst, 96(21): 1593-603. [Abstract] [Full-text]
15. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis.
    Lancet Oncol, 5(11): 673-80. [Abstract] [Full-text]
16. Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence.
    Eur J Surg Oncol, 30(10): 1107-12. [Abstract] [Full-text]
17. Depletion of activated Vbeta8+ T cells disrupts bispecific antibody directed antitumor immunity.
    J Surg Res, 122(1): 103-12. [Abstract] [Full-text]
18. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
    Dermatol Surg, 30(11): 1371-5; discussion 1375-6. [Abstract] [Full-text]
19. Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes.
    Eur J Immunol, 34(11): 3285-90. [Abstract] [Full-text]
20. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Ann Surg Oncol, 11(11): 988-97. [Abstract] [Full-text]
21. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.
    Ann Surg Oncol, 11(11): 983-7. [Abstract] [Full-text]
22. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
    Oncogene, 23(52): 8509-19. [Abstract] [Full-text]
23. Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells.
    Free Radic Biol Med, 37(11): 1906-15. [Abstract] [Full-text]
24. Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells.
    Int Immunopharmacol, 4(14): 1795-803. [Abstract] [Full-text]
25. In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.
    Exp Cell Res, 301(2): 251-65. [Abstract] [Full-text]
26. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
    Cancer, 101(10): 2247-56. [Abstract] [Full-text]
27. Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility.
    Photodermatol Photoimmunol Photomed, 20(6): 283-8. [Abstract] [Full-text]
28. Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells.
    Gene Ther, 11(23): 1694-702. [Abstract] [Full-text]
29. Pigmented penile macules.
    Int J STD AIDS, 15(11): 717-9. [Abstract] [Full-text]
30. The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties.
    Genes Chromosomes Cancer, 42(1): 10-21. [Abstract] [Full-text]
31. Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
    J Clin Oncol, 22(22): 4474-85. [Abstract] [Full-text]
32. One-year follow-up of a lentigo maligna: first dermoscopic signs of growth.
    Br J Dermatol, 151(5): 1087-9. [Abstract] [Full-text]
33. Small diameter melanoma: a follow-up of the Norwegian Melanoma Project.
    Br J Dermatol, 151(5): 1081-3. [Abstract] [Full-text]
34. Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions.
    Br J Dermatol, 151(5): 1029-38. [Abstract] [Full-text]
35. Comparative histopathology of grey-horse-melanoma and human malignant melanoma.
    Pigment Cell Res, 17(6): 674-81. [Abstract] [Full-text]
36. Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.
    J Clin Oncol, 22(22): 4463-73. [Abstract] [Full-text]
37. Isolated limb perfusion for unresectable melanoma of the extremities.
    Arch Surg, 139(11): 1237-42. [Abstract] [Full-text]
38. Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma.
    Br J Plast Surg, 57(8): 725-7. [Abstract] [Full-text]
39. Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours.
    Mod Pathol, 17(12): 1539-44. [Abstract] [Full-text]
40. Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese.
    Clin Exp Dermatol, 29(6): 600-4. [Abstract] [Full-text]
41. Self-detected cutaneous melanomas in Italian patients.
    Clin Exp Dermatol, 29(6): 593-6. [Abstract] [Full-text]
42. The relation between c-myc expression and interferon sensitivity in uveal melanoma.
    Br J Ophthalmol, 88(12): 1563-7. [Abstract] [Full-text]
43. Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation.
    Br J Ophthalmol, 88(12): 1527-32. [Abstract] [Full-text]
44. Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma.
    Cancer Res, 64(22): 8456-60. [Abstract] [Full-text]
45. Host acid sphingomyelinase regulates microvascular function not tumor immunity.
    Cancer Res, 64(22): 8285-91. [Abstract] [Full-text]
46. Inhibition of melanoma growth and metastasis by ATF2-derived peptides.
    Cancer Res, 64(22): 8222-30. [Abstract] [Full-text]
47. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
    J Natl Cancer Inst, 96(22): 1702-13. [Abstract] [Full-text]
48. Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma.
    Am J Surg, 188(5): 532-7. [Abstract] [Full-text]
49. A rare case of primary malignant melanoma of the scrotum diagnosed by fine-needle aspiration.
    Diagn Cytopathol, 31(6): 413-6. [Abstract] [Full-text]
50. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
    Oncogene, 23(54): 8796-804. [Abstract] [Full-text]
51. Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
    Int J Cancer, 113(2): 259-66. [Abstract] [Full-text]
52. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.
    J Mol Med, 82(11): 735-49. [Abstract] [Full-text]
53. Taurine uptake by human retinal pigment epithelium: implications for the transport of small solutes between the choroid and the outer retina.
    Invest Ophthalmol Vis Sci, 45(12): 4529-34. [Abstract] [Full-text]
54. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    Invest Ophthalmol Vis Sci, 45(12): 4240-6. [Abstract] [Full-text]
55. Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen.
    J Cell Biol, 167(4): 745-56. [Abstract] [Full-text]
56. Primary malignant melanoma of the oral cavity: assessment of outcome from the clinical records of 35 patients.
    Int J Oral Maxillofac Surg, 33(8): 761-5. [Abstract] [Full-text]
57. A Bayesian connectivity-based approach to constructing probabilistic gene regulatory networks.
    Bioinformatics, 20(17): 2918-27. [Abstract] [Full-text]
58. Acceptability and feasibility of a community-based screening programme for melanoma in Australia.
    Health Promot Int, 19(4): 437-44. [Abstract] [Full-text]
59. Genetic similarities between Spitz nevus and Spitzoid melanoma in children.
    Cancer, 101(11): 2636-40. [Abstract] [Full-text]
60. Systemic melanoma metastatic to the retina and vitreous.
    Ophthalmologica, 218(6): 424-33. [Abstract] [Full-text]
61. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
    Mol Ther, 10(6): 1085-95. [Abstract] [Full-text]
62. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization.
    Gene, 343(1): 191-201. [Abstract] [Full-text]
63. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Thromb Res, 115(1): 123-9. [Abstract] [Full-text]
64. Determining the asymmetry of skin lesion with fuzzy borders.
    Comput Biol Med, 35(2): 103-20. [Abstract] [Full-text]
65. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Clin Cancer Res, 10(22): 7685-91. [Abstract] [Full-text]
66. Comparison between ultraviolet-visible and near-infrared elastic scattering spectroscopy of chemically induced melanomas in an animal model.
    J Biomed Opt, 9(6): 1320-6. [Abstract] [Full-text]
67. Design, testing, and clinical studies of a handheld polarized light camera.
    J Biomed Opt, 9(6): 1305-10. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.